The Effect of Antrum Size on Weight Loss, Glucagon-Like Peptide-1 (GLP-1) Levels, and Glycemic Control Following Laparoscopic Sleeve Gastrectomy in Adolescents with Obesity and Type 2 Diabetes

Obes Surg. 2021 Oct;31(10):4376-4385. doi: 10.1007/s11695-021-05590-9. Epub 2021 Aug 5.

Abstract

Purpose: The aim of this study was to compare the effect of antral resection versus antral preservation sleeve gastrectomy on the post-operative GLP-1, glycemic control, and weight loss in adolescents suffering from severe obesity and type 2 diabetes (T2D).

Materials and methods: This study included 36 adolescents. Patients were randomly divided into 2 groups: group (A) and group (B). Each group included 18 patients who underwent LSG, starting transection at 2 cm or 5 cm from the pyloric ring in group (A) and group (B), respectively. They were followed up at 1, 3, 6, 12, and 24 months post-operatively. The outcomes were the post-operative GLP-1 response, glycemic control, weight loss, and safety.

Results: The improvements in the body mass index and the percentage of excess weight loss (%EWL) were statistically significant within each group. The mean GLP-1 levels showed significant increase at the 1, 3, and 6 months but not in the 12 and 24 months in all the studied samples within each group. The mean HbA1c levels and post-prandial serum C-peptide significantly improved within each group (P < 0.05). No statistical differences in the weight loss, %EWL, GLP-1, HbA1c, C-peptide changes, and complication rates were observed between both groups. Diabetic remission was significantly higher (88.9%) in group (A).

Conclusions: LSG resulted in generalized significant GLP-1 initial response that decreased over time. The reduced antrum size did not influence the GLP-1 response, glycemic control, or insulin resistance, but resulted in significantly better T2D remission. Since the study examines a small number of patients, further studies are needed.

Trial registration: ClinicalTrials.gov Identifier: NCT04388059.

Keywords: Adolescent; Antral preservation; Antral resection; C-peptide; Diabetes; GLP-1; Glycemic control; Laparoscopic sleeve gastrectomy; Obesity; T2D.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Body Mass Index
  • Diabetes Mellitus, Type 2* / surgery
  • Gastrectomy
  • Glucagon-Like Peptide 1
  • Glycemic Control
  • Humans
  • Laparoscopy*
  • Obesity, Morbid* / surgery
  • Pediatric Obesity* / surgery
  • Treatment Outcome
  • Weight Loss

Substances

  • Glucagon-Like Peptide 1

Associated data

  • ClinicalTrials.gov/NCT04388059